Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era

Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update

(2021) Masatoshi Kudo et al.   Liver Cancer

Impact of modified albumin–bilirubin grade on survival in patients with HCC who received lenvatinib

(2021) Toshifumi Tada et al.   Scientific Reports

Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective study

(2021) Atsushi Hiraoka et al.   Scientific Reports

Trial Design and Endpoints in hepatocellular carcinoma: AASLD Consensus Conference

(2020) Josep M. Llovet et al.   HEPATOLOGY

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

(2020) Richard S. Finn et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements

(2020) Masatoshi Kudo et al.   Liver Cancer

Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib

(2020) Yuwa Ando et al.   ONCOLOGY

Combination of Mac-2 Binding Protein Glycosylation Isomer and Up-To-Seven Criteria as a Useful Predictor for Child-Pugh Grade Deterioration after Transarterial Chemoembolization for Hepatocellular Carcinoma

(2019) Yuji Eso et al.   Cancers

Prediction of Prognosis of Intermediate-Stage HCC Patients: Validation of the Tumor Marker Score in a Nationwide Database in Japan

(2019) Atsushi Hiraoka et al.   Liver Cancer

Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma

(2019) Atsushi Hiraoka et al.   ONCOLOGY

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study

(2019) Masatoshi Kudo et al.   Cancers

Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolization

(2018) Yutaka Yasui et al.   HEPATOLOGY RESEARCH

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

(2018) Masatoshi Kudo et al.   LANCET

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

(2018) Ghassan K. Abou-Alfa et al.   NEW ENGLAND JOURNAL OF MEDICINE

Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis

(2018) Atsushi Hiraoka et al.   Liver Cancer

Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule - a retrospective study

(2018) Tsuyoshi Shimamura et al.   TRANSPLANT INTERNATIONAL

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

(2017) Jordi Bruix et al.   LANCET

New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization

(2017) Jin Hyoung Kim et al.   LIVER INTERNATIONAL

Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function

(2017) Atsushi Hiraoka et al.   Liver Cancer

Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma

(2016) Atsushi Hiraoka et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin Grade

(2016) Atsushi Hiraoka et al.   ONCOLOGY

Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)

(2015) Norihiro Kokudo et al.   HEPATOLOGY RESEARCH

Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade

(2015) Philip J. Johnson et al.   JOURNAL OF CLINICAL ONCOLOGY

Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma

(2015) Tadaaki Arizumi et al.   Liver Cancer

EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease

(2015)   JOURNAL OF HEPATOLOGY

Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update

(2014) Masatoshi Kudo et al.   ONCOLOGY

Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization

(2014) Sadahisa Ogasawara et al.   ONCOLOGY

Intermediate hepatocellular carcinoma: current treatments and future perspectives

(2013) J.- F. Dufour et al.   ANNALS OF ONCOLOGY

Epidemiology of Hepatocellular Carcinoma

(2013) Sahil Mittal et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

The ART-strategy: Sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE

(2013) Florian Hucke et al.   JOURNAL OF HEPATOLOGY

Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions

(2013) Andrew Burroughs et al.   SEMINARS IN LIVER DISEASE

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging

(2011) Katsuhiro Sano et al.   RADIOLOGY

Intraindividual Comparison of Gadoxetate Disodium–enhanced MR Imaging and 64-Section Multidetector CT in the Detection of Hepatocellular Carcinoma in Patients with Cirrhosis

(2010) Michele Di Martino et al.   RADIOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE